Lisa Maher Selected Research

Methadone (Dolophine)

1/2020	Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic.
5/2015	Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.
12/2009	Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa Maher Research Topics

Disease

47	Infections 01/2024 - 10/2006
21	Hepatitis C 01/2023 - 12/2007
12	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2023 - 01/2009
6	COVID-19 03/2024 - 01/2020
6	HIV Infections (HIV Infection) 05/2020 - 01/2015
5	Liver Diseases (Liver Disease) 01/2020 - 11/2013
4	Erectile Dysfunction 01/2020 - 01/2017
4	Coinfection 01/2016 - 07/2012
3	Hepatitis B 11/2021 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 07/2018 - 05/2017
2	Reinfection 04/2024 - 11/2015
2	Persistent Infection 01/2020 - 01/2017
2	Viremia 02/2019 - 01/2019
2	Fibrosis (Cirrhosis) 01/2019 - 10/2009
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2013 - 02/2012
1	Chronic Disease (Chronic Diseases) 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2022
1	Virus Diseases (Viral Diseases) 11/2021
1	Seizures (Absence Seizure) 01/2019
1	Carcinoma (Carcinomatosis) 07/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Jaundice (Icterus) 01/2016
1	Substance-Related Disorders (Drug Abuse) 01/2016
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 05/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2012
1	Chronic Hepatitis C 10/2010
1	Rheumatoid Arthritis 10/2010
1	Drug Overdose 04/2009

Drug/Important Bio-Agent (IBA)

17	VaccinesIBA 03/2024 - 11/2009
13	Antiviral Agents (Antivirals)IBA 01/2024 - 07/2012
10	RNA (Ribonucleic Acid)IBA 08/2021 - 10/2014
7	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021 - 01/2011
6	Opioid Analgesics (Opioids)IBA 01/2023 - 09/2014
6	Heroin (Diamorphine)IBA 10/2014 - 07/2007
5	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2023 - 01/2017
4	Broadly Neutralizing AntibodiesIBA 04/2024 - 01/2017
3	AntibodiesIBA 04/2024 - 01/2016
3	Methadone (Dolophine)FDA LinkGeneric 01/2020 - 12/2009
3	Cocaine (Cocaine HCl)IBA 01/2020 - 10/2006
2	AntigensIBA 04/2024 - 07/2019
2	EpitopesIBA 01/2020 - 01/2017
2	Amyl NitriteIBA 01/2020 - 01/2017
2	Illicit Drugs (Recreational Drugs)IBA 01/2019 - 05/2015
2	Interferon LambdaIBA 01/2016 - 11/2014
2	Anti-Infective Agents (Microbicides)IBA 01/2009 - 09/2008
1	Immunoglobulin G (IgG)IBA 01/2024
1	Lipoprotein(a)IBA 07/2022
1	COVID-19 VaccinesIBA 01/2022
1	Immunodominant EpitopesIBA 01/2020
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2020
1	Neutralizing AntibodiesIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	InterferonsIBA 01/2017
1	UK-4IBA 01/2017
1	Phosphodiesterase 5 InhibitorsIBA 01/2017
1	Opiate AlkaloidsIBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2016
1	ORALIT (ORS)IBA 05/2015
1	Nucleic AcidsIBA 05/2015
1	ElementsIBA 06/2013
1	Biomarkers (Surrogate Marker)IBA 06/2013
1	Abatacept (Orencia)FDA Link 10/2010
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2010

Therapy/Procedure

11	Therapeutics 01/2023 - 10/2010
8	Condoms (Condom) 07/2023 - 11/2011
7	Opiate Substitution Treatment 05/2018 - 10/2012
2	Art Therapy 01/2021 - 11/2013
1	Patient Isolation 01/2020
1	Ambulatory Care (Outpatient Care) 01/2020
1	Long-Acting Reversible Contraception 01/2020
1	Time-to-Treatment 10/2018
1	Off-Label Use 01/2017
1	Aftercare (After-Treatment) 11/2016
1	Treatment Delay 03/2015
1	Mechanical Ventilators (Ventilator) 01/2015
1	Highly Active Antiretroviral Therapy (HAART) 02/2012
1	Liver Transplantation 10/2009